This is a demo store. No orders will be fulfilled.
首页
400-620-6333
脑与神经疾病靶点
选项
-
Recombinant Mouse GM-CSF Protein种属: 小鼠(Mouse) Accession #: Q14AD9表达系统: HEK293 蛋白标签: N-His 内毒素水平: <0.1 EU/μg生物活性: Measured in a cell proliferation assay using FDC-P1 cells. The ED50 for this effect is typically 0.04-0.17 ng/mL, corresponding to a specific activity of 5.88×10^6~2.5×10^7 units/mg.
-
Recombinant Mouse Cathepsin B Protein种属: 小鼠(Mouse) Accession #: P10605表达系统: HEK293 蛋白标签: C-10His 内毒素水平: <0.1 EU/μg生物活性: Measured by its ability to cleave the fluorogenic peptide substrate Z-LR-AMC. The specific activity is >2,000 pmol/min/µg, as measured under the described conditions.
-
Recombinant Mouse gp130 Protein种属: 小鼠(Mouse) Accession #: Q6PDI9表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by its ability to inhibit IL-6-dependent proliferation of the 7TD1 mouse hybridoma cells in the presence of Recombinant Human IL-6 R alpha. The ED50 for this effect is 1.8 ng/mL.
-
Recombinant Mouse EGFR Protein种属: 小鼠(Mouse) Accession #: Q9EP98表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by its ability to bind recombinant human EGF in a functional ELISA with an estimated Kd of <10 nM.
-
Recombinant Mouse CD25/IL-2R alpha Protein种属: 小鼠(Mouse) Accession #: Q544I2表达系统: HEK293 蛋白标签: C-10His 内毒素水平: <0.1 EU/μg生物活性: Measured by its ability to inhibit the IL-2-dependent proliferation of MO7e human megakaryocytic leukemic cells. The ED50 for this effect is 0.045-0.3 µg/mL in the presence of 30 ng/mL of recombinant human IL-2.
-
Recombinant Mouse Alpha-synuclein Protein种属: 小鼠(Mouse) Accession #: O55042表达系统: E. coli 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Mouse Alpha-synuclein Protein (rp183595) at 1.0 μg/mL can bind Alpha-synuclein Mouse mAb (Ab185363) with the EC50 of 19.8 ng/mL. Immobilized Recombinant Mouse Alpha-synuclein Protein (rp183595) at 1.0 μg/mL can bind Alpha-synuclein Mouse mAb (Ab185365) with the EC50 of 28.3 ng/mL. Immobilized Recombinant Mouse Alpha-synuclein Protein (rp183595) at 5.0 μg/mL can bind Cinpanemab (anti-Alpha-synuclein) (Ab176594) with the EC50 of 475.3 ng/mL.
